Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Matthew D. Hellmann | Researchclopedia

Back to researchers

Matthew D. Hellmann

Memorial Sloan Kettering Cancer Center ORCID

835

Works

97,994

Citations

116

h-index

268

i10-index

Research Topics

Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations Cancer Genomics and Diagnostics

Affiliations

AstraZeneca (United Kingdom)2023–2023

Loyola University Medical Center2018–2018

Hudson Institute2019–2021

Memorial Sloan Kettering Cancer Center2013–2025

The University of Texas MD Anderson Cancer Center2020–2020

Top Works

Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

Naiyer A. Rizvi,Matthew D. Hellmann,et al.

20157,869 citations

Lung Cancer Research Studies

Lung Cancer Diagnosis and Treatment

Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

Edward B. Garon,Naiyer A. Rizvi,et al.

20156,161 citations

Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

Bertrand Routy,Emmanuelle Le Chatelier,et al.

20175,251 citations

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

Michael A. Postow,Robert Sidlow,et al.

20184,515 citations

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

Robert Samstein,Chung‐Han Lee,et al.

20194,303 citations

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Ahmet Zehir,Ryma Benayed,et al.

20173,459 citations

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

Matthew D. Hellmann,Tudor–Eliade Ciuleanu,et al.

20183,116 citations

Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade

Nicholas McGranahan,Andrew J.S. Furness,et al.

20163,058 citations

Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer

Matthew D. Hellmann,Luis Paz‐Ares,et al.

20192,793 citations